Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems

NEXT STORY
North America Wipes Market Worth $15+ Billion by 2027 – Growing Demand for Wipes due to the Outbreak of COVID-19
PREV STORY
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Business in New England
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunovaccine Announces Achievement of Milestones in Collaboration with Zoetis to Develop Veterinary Vaccines

HALIFAX, Nova Scotia, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

author_avatar
NASDAQ Market News

Iovance Biotherapeutics to Present Data at Upcoming ESMO 2017 Congress on Tumor-Infiltrating Lymphocyte Treatment for Lymphoma Indications

SAN CARLOS, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a ...

author_avatar
NASDAQ Market News

Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp

author_avatar
NASDAQ Market News